Peppermint oil absorption data needed for safety assessment, FDA tells CIR.
This article was originally published in The Rose Sheet
Executive Summary
PEPPERMINT OIL ABSORPTION DATA NEEDED FOR CIR SAFETY ANALYSIS, FDA Office of Cosmetics and Colors Skin Absorption and Metabolism Section Chief Robert Bronaugh, PhD, told the Cosmetic Ingredient Review Expert Panel at its June 6 meeting in Washington, D.C. Bronaugh presented the panel with an FDA exposure assessment based on CIR data and explained that use of a marketed .2% peppermint oil body spray when assuming absorption of 100% would result in an exposure level far exceeding the no-effect level found in animal tests (the concentration of a product that can be safely absorbed). FDA "is a little bit concerned about the fact that we don't know the absorption of this material," Bronaugh said